We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWatkin Jones Regulatory News (WJG)

Share Price Information for Watkin Jones (WJG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 44.60
Bid: 44.60
Ask: 44.75
Change: -1.00 (-2.19%)
Spread: 0.15 (0.336%)
Open: 46.65
High: 46.65
Low: 44.60
Prev. Close: 45.60
WJG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Pre-Close and COVID-19 Update

1 Apr 2020 14:00

RNS Number : 4435I
Watkin Jones plc
01 April 2020
 

For immediate release

1 April 2020

 

 

Watkin Jones plc

('Watkin Jones' or the 'Group')

 

Pre-Close and COVID-19 Update

 

'Resilient business responding to the unprecedented challenge of COVID-19'

 

Watkin Jones plc (AIM:WJG), the UK's leading developer and manager of residential for rent, with a focus on the student accommodation and Build to Rent sectors, announces a pre-close update for the half year ended 31 March 2020 (the 'period' or 'H1-2020') and comments on the impact of COVID-19.

 

Pre-Close update for the six months ended 31 March 2020

 

The Group's trading remained strong through the first half of the year. All business segments performed well, delivering on their operational objectives, with the disruption caused by COVID-19 only starting to have an effect on our operations towards the end of March 2020. As a result, the Board expects to report revenues and earnings for H1-2020 in line with its expectations.

 

Continued progress was made during the period in growing the pipeline of sites for future development and in achieving forward sales of assets to the Group's high-quality institutional client base, including:

 

· Forward sale of a 348 bed PBSA scheme at Wilder Street, Bristol, for delivery in FY21;

· Agreement, with planning consent, to increase the forward sold PBSA development at Kelaty House, Wembley by 100 beds;

· Secured two further PBSA sites in Bristol (291 beds) and Bath (300 beds);

· Secured two further significant BtR sites in Birmingham (565 apartments) and Bath (323 apartments).

 

Including these additions, the Group's forward sold and secured PBSA development pipeline comprises over 7,000 beds, across 19 sites, with 12 sites (4,985 beds) forward sold. On the same basis, the Group's BtR pipeline stands at over 2,600 apartments, across 10 sites, with five developments (1,012 apartments) forward sold. The Group has a number of additional opportunities, in both sectors, which provide scope to further expand the development pipeline.

 

The performance in the first half reflects the continued strength of demand during the period for well-located assets in the Group's target cities and the recognition of Watkin Jones as a preferred development partner.

 

The impact of COVID-19

 

As announced on 27 March, we have begun to experience significant disruption to our operations as a result of the COVID-19 outbreak. Our non-site based staff are currently working from home, in line with our established Business Continuity Plan, and we have halted all non-essential work on our construction sites. This will inevitably impact financial performance, whilst these measures are in place. We have a strong forward sold delivery pipeline for delivery over the next two years. However, it is difficult to predict the scale of adverse impacts caused by further disruption to our operations, or to forward sale markets, at this time. The Board therefore believes that it is appropriate to withdraw financial guidance at the current time, with the intention to reinstate it as soon as the backdrop becomes more stable.

 

Notwithstanding the challenging current backdrop, the Board believes that the long-term outlook for both the student accommodation and BtR sectors remains strong. These markets are underpinned by robust fundamental growth drivers, which will continue to appeal to institutional investors. The Group is confident of further enhancing its position as a market leader over time.

 

Liquidity

 

Watkin Jones has entered this unprecedented period of market uncertainty well positioned, with a 'capital light' business model. The Group has forward sold all of its 2020 developments and eight out of ten of its developments scheduled for delivery in 2021 to institutional partners, which provides cashflow and earnings visibility. At 31 March 2020, the Group had a gross cash balance of circa £71 million and a net cash balance after deducting site specific loans of circa £36 million. In addition, the Group has in place a £60 million RCF to primarily support land procurement and development opportunities, of which only £29 million was drawn down as at 31 March 2020.

 

Whilst the Group has a resilient financial position, the Board believes it is prudent to adopt a cautious approach to new investment, as well as to introduce measures to manage costs and conserve cash, until the extent and duration of the disruption caused by COVID-19 is better understood. The Board therefore does not intend to declare an interim dividend alongside its results for the six months to 31 March 2020. It will reinstate dividend payments as soon as appropriate. Furthermore, the executive directors will not receive an annual pay increase, which would otherwise have been due on 1 April 2020, and until normal construction activity is resumed, the non-executive directors will waive 20% of their fees.

 

Cladding review

 

In our FY19 full year results announcement on 14 January 2020 we advised that the integrity of cladding systems and fire protection measures was a matter of ongoing review. In response to revised government guidance on the suitability of certain cladding solutions, published on 20 January 2020, we have been working with the owners of the buildings we have developed in order to determine if any remedial actions are required. All of Watkin Jones' developments have been constructed in compliance with prevailing building regulations at the time but, given the change to guidance, the Group believes it is right to engage with building owners proactively to ensure any changes are made as expediently as possible.

 

Whilst discussions with certain property owners remain ongoing, the Board currently expects that this will result in a sharing of the initial costs of any remedial works with them. The gross cost to the Group is currently expected to be in the range of £12 - £15 million over the next two to three years. A one off non-underlying provision for this cost will be made at the year end. The Group believes it may be able to recover some of this cost from the sub-contractors and consultants engaged on implementing the particular cladding systems at the time. This is likely to take an extended period of time to achieve and the extent of any recovery is currently uncertain.

 

Notice of Interim Results

The Group will make a further announcement in due course regarding the timing of its Interim Results.

 

- Ends -

 

The information contained within this announcement is deemed by the Group to constitute inside information as stipulated under the Market Abuse Regulation. Upon the publication of this announcement via Regulatory Information Service, this inside information is now considered to be in the public domain.

 

For further information:

Watkin Jones plc

 

Richard Simpson, Chief Executive Officer

Tel: +44 (0) 1248 362 516

Phil Byrom, Chief Financial Officer

www.watkinjonesplc.com

 

 

Peel Hunt LLP (Nominated Adviser & Joint Corporate Broker)

Tel: +44 (0) 20 7418 8900

Mike Bell / Ed Allsopp

www.peelhunt.com

 

 

Jefferies Hoare Govett (Joint Corporate Broker)

Tel: +44 (0) 20 7029 8000

Max Jones / Will Soutar

www.jefferies.com

 

 

 

 

Media enquiries:

Buchanan

 

Henry Harrison-Topham / Richard Oldworth

Jamie Hooper / Steph Watson

 

Tel: +44 (0) 20 7466 5000

watkinjones@buchanan.uk.com

www.buchanan.uk.com

 

Notes to Editors

Watkin Jones is the UK's leading developer and manager of residential for rent, with a focus on the student accommodation and Build to Rent sectors. The Group has strong relationships with institutional investors, and a reputation for successful, on-time-delivery of high quality developments. Since 1999, Watkin Jones has delivered 41,000 student beds across 123 sites, making it a key player and leader in the UK purpose built student accommodation market. In addition, the Fresh Property Group, the Group's specialist accommodation management company, manages nearly 18,000 student beds and Build to Rent apartments on behalf of its institutional clients. Watkin Jones has also been responsible for over 80 residential developments, ranging from starter homes to executive housing and apartments. The Group is now expanding its operations into the Build to Rent sector.

 

The Group's competitive advantage lies in its experienced management team and business model, which enables it to offer an end-to-end solution for investors, delivered entirely in-house with minimal reliance on third parties, across the entire life cycle of an asset.

 

Watkin Jones was admitted to trading on AIM in March 2016 with the ticker WJG.L. For additional information please visit www.watkinjonesplc.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDBDGDSXUGDGGB
Date   Source Headline
23rd Apr 20247:00 amRNSAppointment of CFO
23rd Apr 20247:00 amRNSHY24 Trading Update
15th Mar 20243:42 pmRNSDirector/PDMR Shareholding
7th Mar 20244:05 pmRNSForward Sale of PBSA Development in Bristol
29th Feb 20245:17 pmRNSResult of AGM
9th Feb 20243:30 pmRNSNotification of Major Holdings
1st Feb 20242:15 pmRNSAnnual Report and Notice of AGM
31st Jan 20241:30 pmRNSDirector/PDMR Shareholding
23rd Jan 20247:00 amRNSFull Year Results 2023
18th Jan 20247:00 amRNSPresentation via Investor Meet Company
10th Jan 20247:00 amRNSNotice of Final Results
14th Dec 20237:00 amRNSChange of Registered Office
16th Nov 20236:20 pmRNSNotification of Major Holdings
15th Nov 20237:00 amRNSAppointment of Chief Executive Officer
24th Oct 20233:46 pmRNSNotification of Major Holdings
19th Oct 202312:43 pmRNSNotification of Major Holdings
12th Oct 20232:24 pmRNSDirector Shareholding
11th Oct 20231:16 pmRNSDirector Shareholding
11th Oct 20237:00 amRNSFY23 Trading Update
3rd Oct 20234:23 pmRNSNotification of Major Holdings
3rd Oct 20234:18 pmRNSCorrection: Notification of Major Holdings
1st Sep 20238:00 amRNSNotification of Major Holdings
17th Aug 20237:00 amRNSSale of three non-core PRS operational assets
19th Jul 20232:52 pmRNSDirector Shareholding
19th Jul 20237:00 amRNSBoard Change
19th Jul 20237:00 amRNSTrading Update
22nd Jun 20233:53 pmRNSNotification of Major Holdings
5th Jun 20237:00 amRNSSuccessful £155m forward sale with L&G and Clanmil
24th May 20237:00 amRNSDirector Shareholding
23rd May 20237:10 amRNSHalf Year Results
15th May 202310:45 amRNSIssue of Equity
13th Apr 20237:00 amRNSH1-2023 Trading Update
28th Feb 20234:00 pmRNSResults of AGM
17th Feb 20237:00 amRNSDirector/PDMR Shareholding
14th Feb 20233:31 pmRNSDirector Shareholding
8th Feb 20237:00 amRNSPresentation via Investor Meet Company
6th Feb 20237:00 amRNSDirector/PDMR Shareholding
2nd Feb 202312:30 pmRNSAnnual Report and Notice of AGM
31st Jan 202312:20 pmRNSDirector Shareholding
27th Jan 202310:51 amRNSProgressive publishes new research
25th Jan 20237:00 amRNSFull Year Results 2022
16th Jan 20232:15 pmRNSNotification of Major Holdings
9th Jan 20237:00 amRNSNotice of Results
13th Oct 202210:27 amRNSProgressive publishes new research
11th Oct 20229:40 amRNSNotification of Major Holdings
10th Oct 20227:00 amRNSBoard Appointments
5th Oct 202212:47 pmRNSDirector Shareholding
4th Oct 20224:00 pmRNSDirector/PDMR Shareholding
4th Oct 20227:00 amRNSFY-2022 Trading Update
1st Aug 202211:45 amRNSConfirmation of Board change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.